BlackRock Inc. - INVIVO THERAPEUTICS HLDGS CO ownership

INVIVO THERAPEUTICS HLDGS CO's ticker is and the CUSIP is 46186M506. A total of 1 filers reported holding INVIVO THERAPEUTICS HLDGS CO in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BlackRock Inc. ownership history of INVIVO THERAPEUTICS HLDGS CO
ValueSharesWeighting
Q1 2022$299,000
-24.5%
867,8090.0%0.00%
Q4 2021$396,000
-34.8%
867,8090.0%0.00%
Q3 2021$607,000
-5.7%
867,8090.0%0.00%
Q2 2021$644,000
-40.3%
867,809
-20.1%
0.00%
Q1 2021$1,079,000
+107800.0%
1,085,509
+162889.3%
0.00%
Q4 2020$1,0000.0%6660.0%0.00%
Q3 2020$1,0000.0%6660.0%0.00%
Q2 2020$1,0000.0%6660.0%0.00%
Q1 2020$1,0006660.00%
Other shareholders
INVIVO THERAPEUTICS HLDGS CO shareholders Q2 2022
NameSharesValueWeighting ↓
IMS Capital Management 20,146$7,0000.00%
VANGUARD GROUP INC 292,603$101,0000.00%
UBS Group AG 25,171$9,0000.00%
IFP Advisors, Inc 1$1,0000.00%
Sugarloaf Wealth Management, LLC 1$00.00%
OSAIC HOLDINGS, INC. 112$00.00%
BANK OF AMERICA CORP /DE/ 5$00.00%
WELLS FARGO & COMPANY/MN 212$00.00%
NORTHERN TRUST CORP 70,536$24,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of INVIVO THERAPEUTICS HLDGS CO shareholders